TCL Archive ACCC Preliminary Report on DRGs Finds Case Mix Can Alter Profit/ Loss Pictures March 29, 1985
TCL Archive An old drug’s 21st century makeover begins with 84-fold price increase. Price hike of procarbazine astonishes brain tumor specialists. May 13, 2005
TCL Archive Three Organizations Publish Guideline For Biomarker Testing for Targeted Therapies April 26, 2013
TCL Archive Revlimid Extends Time To Progression Compared To Placebo In Phase III Trial December 25, 2009
